The MCF7 cell line originates from human breast cancer and has high expression of SCD-1, whereas LNCaP originates from a metastatic human prostate cancer that has previously been shown to exhibit non-canonical pathways of desaturation and elongation. Here, SCD is linked to prostate carcinoma.